Souvik Sarkar, Ph.D.
Affiliations: | 2007 | Yeshiva University, New York, NY, United States |
Area:
Cell BiologyGoogle:
"Souvik Sarkar"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Allan W. Wolkoff | grad student | 2007 | Yeshiva University | |
| (Cytoskeletal-based vesicular trafficking of the bile salt transporter, Ntcp.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Serper M, Evon DM, Stewart PW, et al. (2019) Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals. Journal of General Internal Medicine |
| Evon DM, Sarkar S, Amador J, et al. (2019) Patient-reported symptoms during and after direct acting antiviral therapies for chronic hepatitis C: The PROP UP Study. Journal of Hepatology |
| Mokkarala S, Johnson C, Sarkar S, et al. (2019) Family Practitioner-Directed Hepatitis C Therapy With Direct-Acting Antivirals Achieves High-Sustained Virologic Response in Prison Population. Journal of Correctional Health Care : the Official Journal of the National Commission On Correctional Health Care. 1078345819832875 |
| Mordaunt CE, Kieffer DA, Shibata NM, et al. (2019) Epigenomic signatures in liver and blood of Wilson disease patients include hypermethylation of liver-specific enhancers. Epigenetics & Chromatin. 12: 10 |
| Sarkar S, Corwin MT, Olson KA, et al. (2019) Pilot Study to Diagnose Nonalcoholic Steatohepatitis With Dynamic F-FDG PET. Ajr. American Journal of Roentgenology. 1-9 |
| Kuo A, Liu CH, Spencer B, et al. (2019) THU-321-Fluorodeoxyglucose perfusion and uptake in abdominal organs is associated with hepatic disease state in patients with nonalcoholic fatty liver disease Journal of Hepatology. 70 |
| Kuftinec G, Loehfelm T, Corwin M, et al. (2018) hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents. Hepatic Oncology. 5: HEP06 |
| Evon DM, Stewart PW, Amador J, et al. (2018) A comprehensive assessment of patient reported symptom burden, medical comorbidities, and functional well being in patients initiating direct acting antiviral therapy for chronic hepatitis C: Results from a large US multi-center observational study. Plos One. 13: e0196908 |
| Wang T, Yang W, Karakas S, et al. (2018) NASH in Nondiabetic Endocrine Disorders. Metabolic Syndrome and Related Disorders |
| Wang G, Corwin MT, Olson KA, et al. (2018) Dynamic PET of human liver inflammation: impact of kinetic modeling with optimization-derived dual-blood input function. Physics in Medicine and Biology |